K Number
K971047
Device Name
FUTURA BIOMEDICAL METAL HEMI TOE IMPLANT
Date Cleared
1997-06-20

(91 days)

Product Code
Regulation Number
888.3730
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Indications for use of this implant are: - Hallux limitus or hallux rigidous. . - Painful hallux valgus. . - . Revision of failed previous surgery. - Painful arthritis. .
Device Description
The Metal Hemi Toe implant is a cobalt chrome alloy, one piece implant to supplement first metatarsal phalangeal joint arthroplasty. The implant is designed to replace the base of the proximal phalanx and provide a smooth articular surface for the adjacent metatarsal head. Primary fixation of the grit-blasted version of the device is via a press fit. This is consistent with the description and intended use of the Swanson Titanium Great Toe Implant. The titanium plasma spray coated version of this device is intended for use with bone cement.
More Information

No
The summary describes a physical implant and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.

Yes
The device is an implantable prosthesis designed to treat painful conditions of the foot joint, such as hallux limitus, hallux rigidous, painful hallux valgus, painful arthritis, and failed previous surgeries, by replacing the damaged joint surface. This directly addresses medical conditions to improve patient health.

No

The device is an implant designed to replace part of a joint in the foot. Its intended use is for treatment of conditions like hallux rigidus or painful arthritis, not for diagnosing them.

No

The device description clearly states it is a "Metal Hemi Toe implant" made of "cobalt chrome alloy" and is a "one piece implant" designed to replace a bone structure. This indicates a physical, hardware-based medical device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Description: The description clearly states that this is a "Metal Hemi Toe implant" designed to be surgically implanted to replace a joint in the foot.
  • Intended Use: The intended uses are all related to treating conditions affecting the first metatarsal phalangeal joint through surgical intervention (arthroplasty).

The device is a surgical implant, not a diagnostic test performed on a sample outside the body.

N/A

Intended Use / Indications for Use

The Metal Hemi Toe implant is a cobalt chrome alloy, one piece implant to supplement first metatarsal phalangeal joint arthroplasty. The implant is designed to replace the base of the proximal phalanx and provide a smooth articular surface for the adjacent metatarsal head. Primary fixation of the grit-blasted version of the device is via a press fit. This is consistent with the description and intended use of the Swanson Titanium Great Toe Implant. The titanium plasma spray coated version of this device is intended for use with bone cement.

Indications for use of this implant are:

  • Hallux limitus or hallux rigidous. .
  • Painful hallux valgus. .
  • . Revision of failed previous surgery.
  • Painful arthritis. .

Product codes (comma separated list FDA assigned to the subject device)

KWD

Device Description

The Metal Hemi Toe implant is a cobalt chrome alloy, one piece implant to supplement first metatarsal phalangeal joint arthroplasty. The implant is designed to replace the base of the proximal phalanx and provide a smooth articular surface for the adjacent metatarsal head.

The implant has an anatomic design which helps minimize the complications often seen with arthroplasty of this joint such as: joint instability, shortening of the hallux, painful or limited range of motion. The thin inferior aspect allows the normal anatomic insertion of the flexor brevis tendon to be maintained.

There are two versions of the Metal Hemi Toe. One version has a roughened grit blasted surface on the stem and back surfaces in contact with the resected base of the phalanx. The other version is coated with a rough coating of titanium plasma spray to encourage osseous ingrowth.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

first metatarsal phalangeal joint

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K864492

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K911378

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 888.3730 Toe joint phalangeal (hemi-toe) polymer prosthesis.

(a)
Identification. A toe joint phalangeal (hemi-toe) polymer prosthesis is a device made of silicone elastomer intended to be implanted to replace the base of the proximal phalanx of the toe.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image shows the logo for Futura Biomedical. The logo consists of a black square with a white "F" inside, followed by the word "FUTURA" in large, bold, black letters. Below "FUTURA" is the word "BIOMEDICAL" in smaller, bold, black letters. There is a black line separating the two words.

JUN 20 1997

510(k) Summary

Submitted by:

Jamal D. Rushdy (Point of Contact) Futura Biomedical, L.L.C. 9369 Carroll Park Drive, Suite A San Diego, CA 92121 (619) 643-5149 (619) 452-9945 facsimile

Date of preparation: June 11, 1997

Trade Name: Futura Biomedical Metal Hemi Toe Implant

Common Name: Metal Hemi Toe Implant

Classification Name: Phalangeal Hemi-Toe Prosthesis per 888.3730 (Class II)

Substantially Equivalent to (predicate device): Swanson Titanium Great Toe Implant by Dow Corning, 510(k) number K864492

Description/Intended Use:

The Metal Hemi Toe implant is a cobalt chrome alloy, one piece implant to supplement first metatarsal phalangeal joint arthroplasty. The implant is designed to replace the base of the proximal phalanx and provide a smooth articular surface for the adjacent metatarsal head. Primary fixation of the grit-blasted version of the device is via a press fit. This is consistent with the description and intended use of the Swanson Titanium Great Toe Implant. The titanium plasma spray coated version of this device is intended for use with bone cement.

Indications for use of this implant are:

  • Hallux limitus or hallux rigidous. .
  • Painful hallux valgus. .
  • . Revision of failed previous surgery.
  • Painful arthritis. .

Technological Characteristics:

The implant has an anatomic design which helps minimize the complications often seen with arthroplasty of this joint such as: joint instability, shortening of the hallux, painful or limited range of motion. The thin inferior aspect allows the normal anatomic insertion of the flexor brevis tendon to be maintained.

There are two versions of the Metal Hemi Toe. One version has a roughened grit blasted surface on the stem and back surfaces in contact with the resected base of the phalanx. The other version is coated with a rough coating of titanium plasma spray to encourage osseous ingrowth.

The main difference between the Metal Hemi Toe and the Swanson Titanium Great Toe is the material. While the Metal Hemi Toe and Swanson Titanium Great Toe are both metallic implants, the Metal Hemi Toe is fabricated mainly of a Cobalt Chrome Alloy rather than Titanium. Both materials are widely used in metallic implants, but Cobalt Chrome is generally favored as an articular surface. Cobalt Chrome is currently used as

1

an articular surface for a phalangeal hemi toe (ref 510(k) K911378 BIOPRO, INC.), and has a 40 year history, as reported by Townley and Taranow. The American Society for Testing of Materials (ASTM) has developed voluntary standards for the materials used in the Metal Hemi Toe:

F 67, Standard Specification for Unalloyed Titanium for Surgical Implant Applications F 75, Standard Specification for Unalloyed Cast Cobalt-Chromium-Molybdenum for Surqical Implant Applications

Conclusions:

The Metal Hemi Toe and Swanson Titanium Great Toe are both metallic hemi prosthesis used to supplement first metatarsal phalangeal joint arthroplasty. They are both onepiece, single stemmed implants which press fit into the intramedullary canal of the proximal phalanx. They both have a curved articular surface for the first metatarsal head to articulate against. The Metal Hemi Toe is offered in sizes that fit within the size range of the Swanson Titanium Great Toe Implant.

The main difference between the two devices is the materials. Cobalt chrome is commonly used in implant fabrication. There are published studies of metallic hemi toe implants using either cobalt chrome (Townley and Taranow) or titanium (Leavitt et. al.), and numerous studies of the use of both of these materials in general in orthopaedic implants. In addition, there are published ASTM standards for the component materials which are intended for surgical implant applications. Based on these data, and the comparisons described above, we feel the material difference of the substrate material (cobalt chrome) from the predicate device (titanium) does not adversely affect the safety and effectiveness of the device, and that the Futura Biomedical Hemi Toe Implant is substantially equivalent to the Dow Corning Swanson Titanium Great Toe Implant.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with outstretched wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the bird symbol. The logo is black and white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 20 1997

Mr. Jamal D. Rushdy General Manager. Futura Biomedical, L.́L.C. 9369 Carroll Park Drive, Suite A San Diego, California 92121

Re : K971047 Metal Hemi Toe Implant Trade Name: Regulatory Class: II Product Code: KWD Dated: March 19, 1997 Received: March 21, 1997

Dear Mr. Rushdy:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) requlation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will

3

Page 2 - Mr. Jamal D. Rushdy

verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D.
Director
Division of General and
Restorative Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

4

510(k) Number: K971047

Device Name: Metal Hemi Toe

The titanium plasma spray coated version of this device is intended for use with bone cement.

Indications for Use:

  • . Hallux limitus or hallux rigidous.
  • . Painful hallux valgus.
  • . Painful arthritis.

Concurrence of CDRH, Office of Device Evaluation (ODE)

  • (Division Sign-Off)
    Division of General Restorative Devices K971047
    510(k) Number

Prescription Use_ (Per 21 CFR 801.109)

Over-The-Counter-Use__________________________________________________________________________________________________________________________________________________________